Axial signs and magnetic resonance imaging correlates in Parkinson's disease

Canadian Journal of Neurological Sciences

Volumn 34, Issue 1, 2007, Pages 56-61

  Acharya, Hernish J ^a   Bouchard, Thomas P ^a   Emery, Derek J ^a   Camicioli, Richard M ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GLENROSE REHABILITATION HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; BRAIN VENTRICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; GAIT; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; UNIFIED PARKINSON DISEASE RATING SCALE; VOLUMETRY; WALKING; WHITE MATTER;

EID: 33947259972     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100005795     Document Type: Article

References (43)

1. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol. 2000; 247 Suppl 2: II3-10.
2. Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, et al. Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol. 2005; 62: 467-72.
3. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 1987; 37: 1539-42.
4. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry. 1989; 52: 201-6.
5. Blin J, Dubois B, Bonnet AM, Vidailhet M, Brandabur M, Agid Y. Does aging aggravate parkinsonian disability? J Neurol Neurosurg Psychiatry. 1991; 54: 780-2.
6. Camicioli R, Moore MM, Sexton G, Howieson DB, Kaye JA. Age-related brain changes associated with motor function in healthy older people. J Am Geriatr Soc. 1999; 47: 330-4.
7. Schneider E, Becker H, Fischer PA, Grau H, Jacobi P, Brinkmann R. The course of brain atrophy in Parkinson's disease. Arch Psychiatr Nervenkr.1979; 227: 89-95.
8. Kitani M, Kobayashi S, Yamaguchi S. Computerized tomography with longitudinal follow-up of brain atrophy in patients with Parkinson's disease. Gerontology. 1990; 36: 361-8.
9. Starkstein SE, Leiguarda R. Neuropsychological correlates of brain atrophy in Parkinson's disease: a CT-scan study. Mov Disord. 1993; 8: 51-5.
10. Steiner I, Gomori JM, Melamed E. Features of brain atrophy in Parkinson's disease. A CT scan study. Neuroradiology. 1985; 27: 158-60.
11. Durif F, Pollak P, Hommel M, Ardouin C, Le Bas JF, Crouzet G, et al. Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease. Eur Neurol. 1992; 32: 32-6.
12. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm. 2001; 108: 571-80.
13. Alegret M, Junque C, Pueyo R, Valldeoriola F, Vendrell P, Tolosa E, et al. MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease. Neurologia. 2001; 16: 63-9.
14. Piccini P, Pavese N, Canapicchi R, Paoli C, Del Dotto P, Puglioli M, et al. White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol. 1995; 52: 191-4.
15. Beyer MK, Aarsland D, Greve OJ, Larsen JP. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord. 2006; 21: 223-9.
16. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990; 40: 1529-34.
17. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001; 58: 1611-15.
18. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien J T, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006; 77: 585-9.
19. Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology. 2000; 55: 539-44.
20. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003; 18: 467-86.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology. 2001; 57: S11-26.
22. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43: 2412-14.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-98.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Washington, D.C.: American Psychiatric Association, 2000.
25. Gancher ST. Scales for the assessment of movement disorders. Handbook of neurologic rating scales 1997:81-106.
26. Brown GG, Rahill AA, Gorell JM, McDonald C, Brown SJ, Sillanpaa M, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol. 1999; 12: 180-8.
27. Eritaia J, Wood SJ, Stuart GW, Bridle N, Dudgeon P, Maruff P, et al. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med. 2000; 44: 973-7.
28. Buchsbaum MS, Yang S, Hazlett E, Siegel BV, Jr., Germans M, Haznedar M, et al. Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res. 1997; 27: 45-53.
29. Brambilla P, Harenski K, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ, et al. MRI study of posterior fossa structures and brain ventricles in bipolar patients. J Psychiatr Res. 2001; 35: 313-22.
30. Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol. 2001; 22: 1483-9.
31. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001; 32: 1318-22.
32. Zar J. Comparing simple linear regression equations. In: Ryu T, editor. Biostatistical analysis. Upper Saddle River: Prentice-Hall; 1999. p.360-8.
33. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord. 2003; 18: 784-90.
34. Camicioli RM, Korzan JR, Foster SL, Fisher NJ, Emery DJ, Bastos AC, et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett. 2004; 354: 177-80.
35. Schneider E, Fischer PA, Jacobi P, Becker H, Beyer M. Cerebral atrophy and long-term response to levodopa in Parkinson's disease. J Neurol. 1979; 222: 37-43.
36. Becker H, Schneider E, Hacker H, Fischer PA. Cerebral atrophy in Parkinson's disease-represented in CT. Arch Psychiatr Nervenkr. 1979; 227: 81-8.
37. Drayer BP. Imaging of the aging brain. Part I. Normal findings. Radiology. 1988; 166: 785-96.
38. Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain. 2000; 123 (Pt 10): 2077-90.
39. Sohn YH, Kim JS. The influence of white matter hyperintensities on the clinical features of Parkinson's disease. Yonsei Med J. 1998; 39: 50-5.
40. Jellinger KA. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol (Berl). 2003; 105: 415-19.
41. Guerini F, Frisoni GB, Bellwald C, Rossi R, Bellelli G, Trabucchi M. Subcortical vascular lesions predict functional recovery after rehabilitation in patients with L-dopa refractory parkinsonism. J Am Geriatr Soc. 2004; 52: 252-6.
42. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. The Lancet Neurology. 2004; 3: 309.
43. Koller W, O'Hara R, Weiner W, Lang A, Nutt J, Agid Y, et al. Relationship of aging to Parkinson's disease. Adv Neurol. 1987; 45: 317-21.